493 related articles for article (PubMed ID: 12504863)
1. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.
Sherer TB; Kim JH; Betarbet R; Greenamyre JT
Exp Neurol; 2003 Jan; 179(1):9-16. PubMed ID: 12504863
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous rotenone rat model of Parkinson's disease: Dose exploration study.
Zhang ZN; Zhang JS; Xiang J; Yu ZH; Zhang W; Cai M; Li XT; Wu T; Li WW; Cai DF
Brain Res; 2017 Jan; 1655():104-113. PubMed ID: 27876560
[TBL] [Abstract][Full Text] [Related]
3. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.
Höglinger GU; Féger J; Prigent A; Michel PP; Parain K; Champy P; Ruberg M; Oertel WH; Hirsch EC
J Neurochem; 2003 Feb; 84(3):491-502. PubMed ID: 12558969
[TBL] [Abstract][Full Text] [Related]
4. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
Testa CM; Sherer TB; Greenamyre JT
Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
6. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
[TBL] [Abstract][Full Text] [Related]
7. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
8. A highly reproducible rotenone model of Parkinson's disease.
Cannon JR; Tapias V; Na HM; Honick AS; Drolet RE; Greenamyre JT
Neurobiol Dis; 2009 May; 34(2):279-90. PubMed ID: 19385059
[TBL] [Abstract][Full Text] [Related]
9. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.
Kirik D; Rosenblad C; Burger C; Lundberg C; Johansen TE; Muzyczka N; Mandel RJ; Björklund A
J Neurosci; 2002 Apr; 22(7):2780-91. PubMed ID: 11923443
[TBL] [Abstract][Full Text] [Related]
10. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
Tapias V; Cannon JR; Greenamyre JT
J Neurosci Res; 2010 Feb; 88(2):420-7. PubMed ID: 19681169
[TBL] [Abstract][Full Text] [Related]
11. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.
Caboni P; Sherer TB; Zhang N; Taylor G; Na HM; Greenamyre JT; Casida JE
Chem Res Toxicol; 2004 Nov; 17(11):1540-8. PubMed ID: 15540952
[TBL] [Abstract][Full Text] [Related]
12. Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment.
Carriere CH; Kang NH; Niles LP
Exp Toxicol Pathol; 2017 Feb; 69(2):109-114. PubMed ID: 27986376
[TBL] [Abstract][Full Text] [Related]
13. Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
Betarbet R; Sherer TB; MacKenzie G; Garcia-Osuna M; Panov AV; Greenamyre JT
Nat Neurosci; 2000 Dec; 3(12):1301-6. PubMed ID: 11100151
[TBL] [Abstract][Full Text] [Related]
14. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
[TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone.
Inden M; Kitamura Y; Takeuchi H; Yanagida T; Takata K; Kobayashi Y; Taniguchi T; Yoshimoto K; Kaneko M; Okuma Y; Taira T; Ariga H; Shimohama S
J Neurochem; 2007 Jun; 101(6):1491-1504. PubMed ID: 17459145
[TBL] [Abstract][Full Text] [Related]
16. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
[TBL] [Abstract][Full Text] [Related]
17. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally.
Ling Z; Chang QA; Tong CW; Leurgans SE; Lipton JW; Carvey PM
Exp Neurol; 2004 Dec; 190(2):373-83. PubMed ID: 15530876
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.
Monti B; Gatta V; Piretti F; Raffaelli SS; Virgili M; Contestabile A
Neurotox Res; 2010 Feb; 17(2):130-41. PubMed ID: 19626387
[TBL] [Abstract][Full Text] [Related]
19. Chronic inhalation of rotenone or paraquat does not induce Parkinson's disease symptoms in mice or rats.
Rojo AI; Cavada C; de Sagarra MR; Cuadrado A
Exp Neurol; 2007 Nov; 208(1):120-6. PubMed ID: 17880941
[TBL] [Abstract][Full Text] [Related]
20. Interaction between subclinical doses of the Parkinson's disease associated gene, α-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats.
Naughton C; O'Toole D; Kirik D; Dowd E
Behav Brain Res; 2017 Jan; 316():160-168. PubMed ID: 27585560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
